Reaction
Device Use Confusion reporting signals
As of the last recalculation, Device Use Confusion appears in 493 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE (PRR 75.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 18 | 75.5 | 75.6 |
| Oral Semaglutide | 59 | 38.4 | 38.4 |
| Umeclidinium | 7 | 33.5 | 33.5 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 30 | 32.5 | 32.5 |
| Somatropin | 40 | 24.9 | 24.9 |
| Risperidone | 60 | 21.6 | 21.6 |
| Fluticasone Furoate And Vilanterol Trifenatate | 17 | 20.6 | 20.6 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 6 | 15.3 | 15.3 |